David D. O'Toole - 21 Jan 2025 Form 4 Insider Report for AVITA Medical, Inc. (RCEL)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	RCEL	Stock Options (Right to Buy)	Award	$0	+150,000		$0.000000	150,000	21 Jan 2025	Common Stock	150,000	$8.73	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	These Stock Options vest in three equal annual installments beginning the first anniversary of the grant date.